recall
saveBreckenridge Pharmaceutical, Inc. recall (Cls II)
March 19, 2025updated 5mo ago
community read0 votes
Duloxetine Delayed-Release Capsules, USP, 60mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit. — Status: Ongoing
view source ↗Data sources
last refreshed 43m ago
Found something off?
same company · ±60 days · 5
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Mar 19, 2025
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Mar 19, 2025
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Apr 9, 2025
- recallBreckenridge Pharmaceutical, Inc recall (Cls II)Apr 30, 2025
- recallBreckenridge Pharmaceutical, Inc recall (Cls II)Apr 30, 2025
comments(0)
5-min edit window · permanent after that